Skip to main content

We are currently seeking participants for our HIV prevention studies. These studies are designed to investigate ways of preventing HIV acquisition.

 

Merck8591- 022

“Evaluation of the efficacy and safety of oral Islatravir as a pre-exposure prophylaxis in cisgender women at high risk for HIV-1 Infection”

Are you HIV negative, curious about prevention research? You may be interested in participating in our clinical study for an HIV preventative medication. Participants will receive study medication & clinical study-related care at no cost. Participants can earn up to $2,100 by participating in this clinical trial.

Merck8591- 024

“Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as pre-exposure prophylaxis in cisgender men and transgender women who have sex with men and are at high risk for HIV-1”

Are you HIV negative, curious about prevention research? You may be interested in participating in our clinical study for an HIV preventative medication. Participants will receive study medication & clinical study-related care at no cost. Participants can earn up to $1,600 by participating in this clinical trial.

GS-US-528-9023

“Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People ≥ 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection”

Are you HIV negative,